Literature DB >> 4689903

Multiple effects of dexamethasone on protein synthesis and hyperplasia caused by a tumor promoter.

J D Scribner, T J Slaga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4689903

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  The structural relationship of phorbol and cortisol: a possible mechanism for the tumor promoting activity of phorbol.

Authors:  S R Wilson; J C Huffman
Journal:  Experientia       Date:  1976-12-15

2.  The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.

Authors:  Luowei Li; Suneet Shukla; Andrew Lee; Susan H Garfield; David J Maloney; Suresh V Ambudkar; Stuart H Yuspa
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

3.  Dissociation of tumour-promoter-induced effects on prostaglandin release, polyamine synthesis and cell proliferation of 3T3 cells.

Authors:  R Lanz; K Brune
Journal:  Biochem J       Date:  1981-03-15       Impact factor: 3.857

4.  Dissociation of tumor promoter-stimulated ornithine decarboxylase activity and DNA synthesis in mouse epidermis in vivo and in vitro by fluocinolone acetonide, a tumor-promotion inhibitor.

Authors:  U Lichti; T J Slaga; T Ben; E Patterson; H Hennings; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.

Authors:  M Neumann; T Grieshammer; S Chuvpilo; B Kneitz; M Lohoff; A Schimpl; B R Franza; E Serfling
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

Review 6.  Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding.

Authors:  E K Parkinson
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.